This week opens with two realities shaping every conversation in medical real estate. The government shutdown is still in effect and the Medicare telehealth reset that began on October first is now flowing through schedules, cash flow, and lease assumptions. National outlets and agencies continue to confirm the shutdown’s operational drag, even as core Medicare processing remains, which means anything that needs a federal touchpoint can slow and that timing risk needs to be priced in.  Expect more fallout from the telehealth policy cliff. CMS delayed the behavioral health in person rule until October first and the grace period has ended. Several legal and policy briefings now outline what is payable, what is not, and how contractors are handling claims in the near term, including guidance that some claims may be held until Congress decides whether to restore flexibilities or provide retroactive payment. If you have properties tied to hybrid models or Hospital at Home programs, this is the week to pressure test volume and rent coverage with your operators.  Watch Connecticut for acute care signal. The Prospect Medical unwind continues to move through court and board processes, with UConn Health advancing the Waterbury purchase plan and separate bids progressing for Manchester Memorial and Rockville General. These files are teaching lenders and buyers how regulatory history, landlord claims, and credit support follow the real estate. Even if you do not own hospitals, sentiment from these headlines can color credit views on specialty facilities across the same markets.  Keep an eye on public market calendars. Healthcare REIT investor relations teams are lining up third quarter calls, and prepared remarks later this month will set tone on leverage, dispositions, and rent coverage. JLL also tees up its third quarter call, which often includes commentary on medical office and outpatient demand that filters into capital plans. Use this week to set your questions and comps so you can react quickly when disclosures hit.  Finally, note the conference drumbeat. HLTH begins next week in Las Vegas, which means this week is when operators and vendors brief boards, finalize budgets, and float partnership notes. Innovation talk does not replace rent, but it does preview where systems plan to spend on outpatient access, data sharing, and site selection tools heading into year end. If your pipeline depends on growth corridors, track these signals now.  The practical play for the next five business days is simple. Confirm your telehealth exposure asset by asset, add schedule buffers while the shutdown lasts, and stay close to disclosures and court filings that influence credit. The groups that do this homework now will underwrite cleaner and move faster when opportunities appear. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

This was a week where policy pressure set the tone and capital read the room. The federal shutdown rolled on and the post September telehealth reset kept reshaping near term plans for clinics and investors. CMS allowed claims to be submitted but told its contractors to pause payments tied to the expired authorities so that a later fix would not force mass reprocessing. Hospitals also lost the federal waiver that supported hospital at home, which pushed patients back to brick and mortar care unless private coverage filled the gap. For real estate, that means rechecking any rent and throughput assumptions that depended on virtual volume or at home programs.  The shutdown itself showed up in practical ways. Trade groups and physician organizations described reduced federal staffing and slower touchpoints even as core Medicare processing continued. National outlets chronicled the broader consequences, from emergency funding to keep nutrition programs afloat to layoff waves across agencies. In a market where timing is value, that combination argues for bigger schedule cushions on permits, surveys, and reviews.  One of the week’s clearest signals for hospital anchored real estate came out of Connecticut. A bankruptcy judge approved a settlement between Yale New Haven Health and Prospect Medical after their earlier deal collapsed, while separate bids for Prospect hospitals in the state continued to move. Observers also noted the role of Medical Properties Trust as landlord and creditor within the unwinding. Whatever your exposure to acute care, the lesson is straightforward. Regulatory history and lease obligations travel with the asset and they shape lender views across an entire market.  Policy makers also turned up the heat on sale leaseback structures in health care. A Senate proposal backed by Senators Markey, Sanders, and Blumenthal would give HHS review power and restrict agreements that could weaken a health system’s finances while closing certain tax advantages. If that idea gains traction, it could change how systems monetize real estate and how investors underwrite rent durability on hospital related assets.  Public market sentiment reflected the uncertainty. Major health care REITs traded lower through much of the week and investor relations calendars pointed to late month earnings that will add clarity on balance sheet plans and guidance. None of this reads as panic, but it does reinforce the current bias toward stronger tenants and flexible footprints.  Even with the policy noise, outpatient deals kept closing. A fully leased medical office and surgery center in Paradise Valley sold on the first of the month, a Florida medical office changed hands at mid week, and a Boston area medical office traded to an active health care buyer. If you needed a reminder that capital still seeks stable health care income, this was it.  The takeaway for owners and operators is to tighten models rather than hit pause. Confirm where telehealth and at home care touched your revenue lines, build timing buffers while the shutdown persists, stay close to credit and compliance on any hospital adjacent exposure, and keep leaning into outpatient assets with proven operators. The groups that make these adjustments early will protect value while others are still reacting. For a quick read on how this week changes the outlook for your specific markets, I am happy to talk it through. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Get the weekly newsletter: https://www.loveladyperspective.com/contact

For years, cheap money fueled medical real estate growth. Developers could borrow at historically low rates, systems could expand faster, and investors could price in aggressive rent escalations. That chapter is over. Higher interest rates have rewritten the math, forcing every player—from REITs to local developers—to rethink how deals get done and where capital flows next. The immediate effect is visible in deal volume. Transaction velocity has slowed, but pricing on quality assets has held stronger than expected. Medical office, outpatient, and behavioral health facilities with creditworthy tenants are still attracting bids because they offer reliable income in a volatile market. The spread between top-tier assets and everything else, however, is widening. A few basis points of rate difference can erase thin margins, and investors are acting accordingly. Developers are responding by leaning on joint ventures, seller financing, and creative capital stacking to keep projects moving. Build-to-suit models are gaining popularity again, especially for healthcare operators that want control over design without tying up large amounts of equity. Some systems are even stepping in as partial owners to make projects pencil. The structure of capital is getting more flexible, but also more complex. On the valuation side, underwriters are scrutinizing everything—tenant credit, lease term, escalation structure, and reimbursement exposure. Cap rates have adjusted upward in most markets, yet the best assets are still trading with strong competition because capital chasing stability always finds its way to healthcare. The key is focus. Those who understand how to model financing accurately, negotiate flexibility into terms, and partner with operators that can weather rate pressure are still closing deals. The environment may be tighter, but opportunity has not left the table—it just requires sharper execution and better intelligence. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

Ask any developer, lender, or broker in the healthcare real estate space what keeps them up at night, and you will hear the same answer—construction costs. They have not gone down, and they are unlikely to in the near term. Labor shortages, supply chain volatility, and higher financing expenses have made new builds harder to pencil out, pushing many groups to rethink how and where they deploy capital. Operators are becoming more selective with projects, focusing on facilities that drive measurable revenue growth rather than just expansion for the sake of footprint. Many health systems are turning to adaptive reuse, converting retail boxes or underperforming offices into outpatient clinics and specialty centers. Even smaller operators are exploring build-to-suit partnerships to offset upfront costs and lock in predictable lease structures. Investors are adjusting too. Construction risk is being priced into deals more carefully, and forward yields are being reassessed based on realistic delivery timelines rather than optimistic ones. In several markets, we are already seeing investors favor stabilized assets with room for operational improvement over speculative new development. That trend will likely continue into 2026. The takeaway is not that development is slowing—it is getting smarter. The winners will be the groups who understand how to balance cost, timing, and long-term positioning. Those who can identify conversion opportunities and partner with operators early in the planning stage are already finding creative ways to make the numbers work. Healthcare real estate remains a resilient sector, but it is moving into a more disciplined phase. The opportunities are still there—they just require sharper pencils and smarter collaboration. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

For years, healthcare real estate moved as one big category—medical office, senior housing, behavioral health, all bundled together under a single umbrella. That era is ending. Investors, lenders, and operators are thinking in sharper, more defined lanes, and the difference is showing up in how deals are sourced, structured, and priced. Specialization is driving the next phase of growth. Developers who used to build general medical office space are now designing for specific care models like orthopedics, ambulatory surgery, or dialysis. Senior living projects are blending independent and assisted models while weaving in outpatient care. Behavioral health operators are carving out their own footprint entirely. This segmentation is not fragmentation—it is focus. It reflects how healthcare itself has evolved into a network of targeted services rather than a single system hub. The result is that investors need to be more fluent in healthcare operations than ever before. It is no longer enough to know square footage and lease terms; you have to understand how the clinical model works, what reimbursement looks like, and how those variables affect rent sustainability. Assets tied to stable, repeatable procedures with steady payers are commanding premium pricing, while facilities serving more volatile specialties are being underwritten with tighter margins. The upside is that specialization brings opportunity. Niche segments once overlooked by traditional capital—rehab, behavioral, post-acute—are now outperforming broader medical office averages. The groups that dig in, learn the nuances, and build relationships within specific verticals are the ones setting themselves apart. Healthcare real estate is not one-size-fits-all anymore, and that is exactly what makes it so interesting right now. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

Walk into almost any growing metro or suburban market right now and you will see it happening—new outpatient centers rising in places where big hospital campuses used to dominate. The healthcare system is decentralizing, and real estate is leading the shift. Operators are moving services closer to where people live. Surgery, imaging, urgent care, infusion, and physical therapy are being delivered in smaller, more efficient facilities that look and feel like retail. These centers are easier to access, cheaper to build, and faster to open than traditional hospital expansions. For patients, that convenience matters. For health systems and investors, it is about capturing market share without taking on unnecessary capital exposure. From a real estate standpoint, outpatient development is reshaping what makes an asset valuable. Proximity to residential density, strong traffic counts, and flexible layouts now carry more weight than adjacency to a hospital campus. Tenants want spaces that can adapt to changing service lines, and developers who can deliver that flexibility are commanding premium rents. This movement also ties directly into population growth patterns. Fast-growing areas in the South and Midwest are seeing a wave of mid-size medical office and outpatient projects—many anchored by multispecialty groups or regional hospital affiliates. These markets were once considered secondary, but they are quickly becoming the new front line of healthcare delivery. The takeaway is clear. Healthcare real estate is moving out of the tower and into the community. Those who understand this shift early are the ones securing the best sites, the strongest tenants, and the longest-term value. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

Behavioral health has moved from niche to necessity, and the real estate market is finally catching up. What used to be an afterthought in healthcare portfolios is now a primary focus for investors and operators alike. The drivers are both economic and human. Demand is exploding across every region, and while reimbursement can still vary by state, the overall funding environment is far more stable than it was a decade ago. Operators are building leaner facilities, often around outpatient and step-down models that balance care quality with operational efficiency. You are seeing this in everything from small residential treatment centers to adaptive reuse projects where older offices or nursing homes are being turned into psych or recovery programs. These assets tend to have longer lease terms, lower turnover, and tenants that invest heavily in their space—three things that make lenders and investors pay attention. From an investment perspective, behavioral health real estate offers something rare in today’s market: need-based demand. Economic cycles may slow other sectors, but people still seek treatment. That resilience, combined with the sector’s evolving professionalism and institutional capital flowing in, is driving consistent interest. The opportunity now is in specialization and intelligence. Understanding state licensing requirements, zoning hurdles, and payer trends can make or break a deal. The most successful players are blending market knowledge with data-driven insight to identify markets that are both underbuilt and operationally viable. Behavioral health is no longer a side category—it is one of the most dynamic segments in medical real estate. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

Week of October 5 to October 11, 2025 This week will test how fast medical real estate adapts amid seismic policy shifts. With telehealth flexibilities now expired and a federal shutdown in place, the pressure is on. First, the fallout from the telehealth expiration is going to be front and center. As of October 1, many of the Medicare telehealth waivers enacted during COVID have lapsed, including home-based visits and expanded site allowances. That leaves operators that leaned heavily on virtual care squeezed. Providers can still offer telehealth—but unless Congress steps in, reimbursement will be constrained and retroactive coverage remains uncertain.   The American Telemedicine Association has already called on Congress to restore flexibilities and ensure retroactive payment.   This week, expect to see whether legislative or appropriations vehicles include telehealth rescue language. That’s the signal line for whether hybrid care models hold their value. Second, the government shutdown will continue to ripple across approvals, survey timelines, and regulatory pathways. While Medicare payments continue, discretionary agency functions are paused or slowed. That means permit reviews, licensing, certificate of need (CON) decisions, and certain grant flows may lag.   For medical real estate deals in the pipeline, that means schedule buffers are table stakes now. Operator and system moves will also matter. Health systems that have stayed on the sidelines may begin to deploy capital now that reimbursement clarity is under strain and real estate valuations may drift. Look for announcements of clinic openings, acquisitions of outpatient assets, or repositioning efforts—especially in Sunbelt and fast-growing suburban markets, where the outpatient buildout case still holds strength. MOB fundamentals remain resilient, and some markets are still seeing limited supply pressure.   Systems with stronger balance sheets may take advantage of dislocations, accelerating their outpatient footprint.  Watch also how REITs respond. Investors will be dissecting earnings calls and disclosures for clues on how capital is rebalancing in this environment. Medical Properties Trust continues to be in the spotlight as its landlord role intersects with distressed operators.  The week ahead may feel like a test of endurance rather than action. But beneath the stress, there will be signals. Which markets hold up when reimbursement compresses? Which operators can flex their model? Who captures opportunistic ground when quieter assets go on market? If you want help interpreting what these signals mean in your target geography, I’d be glad to walk through them with you. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

This was a pivotal week in healthcare real estate—less for giant deal announcements and more for structural and policy shifts that will ripple through deals, valuations, and operations in the quarters ahead. Telehealth Flexibilities Expire — A Turning Point for Clinics & Investors On October 1, key Medicare telehealth flexibilities expired, bringing an abrupt change to what providers and tenants had come to count on. Many expanded allowances and patients being treated in their homes, urban telehealth, audio-only visits are now off the table or severely restricted again.  CMS implemented a temporary “claims hold” via its Medicare Administrative Contractors to avoid mass reprocessing while lawmakers debate fixes.   This means even claims submitted may not be paid immediately, introducing cash flow uncertainty.  Beyond reimbursement, programs like Hospital-at-Home, which allow inpatient-level care in patient homes, are also in jeopardy.   For medical CRE, the implication is stark: assets built or valued assuming telehealth growth may now require rework or renegotiation. The Government Shutdown Adds Friction to Capital & Operations With Congress failing to pass a funding deal, a government shutdown began October 1. While Medicare payments to providers continue, nonessential agencies slow, and regulatory approvals, surveying, or grant disbursements may halt or drag. That means anything in your pipeline that relies on certifications, state or federal reviews, or subsidy programs needs extra schedule buffer. Hospital Sector Shakeups in CT Draw Attention A spotlight continues to fall on Prospect Medical Holdings’ bankrupt hospital portfolio in Connecticut. This week, Hartford HealthCare formalized a deal to acquire Manchester Memorial and Rockville General for $86 million. The deal comes amid disclosures that one of the Prospect-owned hospitals had received an “Immediate Jeopardy” finding from CMS earlier this year for patient safety, adding regulatory risk to the transaction.  In parallel, UConn Health approved a $13 million bid to acquire Waterbury Hospital’s real estate and operations as part of Prospect’s bankruptcy process.   Legal and consulting fees in the bankruptcy process are mounting and estimated to exceed $100 million by year-end. For medical CRE, these transactions are more than local stories. They affect how lenders and investors view hospital-anchored real estate, creditor priority, and how distressed portfolios might be restructured or sold in future cycles. Transaction Activity & Market Signals Healthcare real estate advisors announced several outpatient and specialty property sales in late September. Among those reported: An outpatient health park in Clifton Park, NY (Class A) was sold.  A specialty outpatient portfolio in Kentucky closed.  A GI/ASC portfolio in Texas transacted (nearly 28,000 SF).  These deals reflect continued investor appetite for smaller, specialized outpatient holdings, especially where operators are strong and lease structures are favorable. On the REIT front, American Healthcare REIT reiterated its positioning and plans, pushing visibility into its portfolio and strategy amid the changing landscape. Meanwhile, Medical Properties Trust remains under scrutiny as its role as landlord in distressed portfolios gains more attention.  What This Means for Medical CRE Players Revisit Telehealth in Your Models Properties underwritten with assumptions of stable telehealth revenue will need stress tests. Assess which parts of your portfolio are exposed (behavioral, diagnostics, follow-up care) and overlay scenario models assuming reduced or delayed reimbursement. Build Timing Buffers Shutdowns, delayed reviews, and CMS holdbacks mean closings and TI (tenant improvement) milestones can slip. Add contingency time to your pipeline and budgets. Watch Distressed Sales as Signals The Prospect CT portfolio is a case study in how distressed hospital real estate can be absorbed with careful underwriting—or ignored at risk. How this plays out will influence risk premiums in hospital-adjacent and specialty facility investing. Lean Into Strong Operators & Diversified Use Outpatient asset sales this week favored specialty, operator-backed deals. The bias is clear: as capital tightens, operators with strong credit, flexible footprints, and diversified services will command the bidding. Stay Ready to React If Congress reinstates telehealth flexibilities retroactively or passes a new extension, valuations will adjust quickly. If they don’t, the market will recalibrate. The advantage will go to those watching policy, adjusting fast, and repositioning intelligently.

Not long ago the focus in healthcare real estate was on large multi-tenant medical office buildings and sprawling senior living campuses. Today the market is paying just as much attention to smaller facilities. Operators are looking at converted retail suites, compact urgent care clinics, micro senior living projects, and specialized outpatient sites that run leaner and serve targeted demand. The reason is simple. Smaller facilities are faster to bring online, easier to finance, and more adaptable to shifting patient needs. They also let operators spread risk across multiple locations instead of anchoring all growth to a single big build. For patients the convenience is hard to beat. Access is quicker, travel times are shorter, and services feel more local. Investors and brokers are starting to recognize that these smaller footprints often come with stronger tenant retention and more predictable cash flow. They also offer creative opportunities for adaptive reuse—old pharmacies becoming dialysis centers or single-story offices transforming into outpatient therapy clinics. What makes this trend worth watching is that it reflects a larger change in how care is delivered. Healthcare is moving closer to the consumer and the real estate is following. Those who know how to spot and position these small but strategic opportunities are already seeing outsized returns. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

Artificial intelligence is no longer just a buzzword in healthcare—it is changing how real estate decisions are made from start to finish. The most obvious impact shows up in site selection. Instead of relying only on demographic snapshots and gut instinct, operators are using AI to layer in payer data, referral networks, traffic counts, and even social determinants of health to pinpoint locations with surgical precision. A process that once took weeks of manual analysis can now be completed in days, giving decision-makers a serious speed advantage. But the influence of AI does not stop at the front end. Owners are applying predictive maintenance tools to extend asset life and lower operating expenses. Patient flow analytics are being used to model throughput and design floorplans that match clinical demand. Energy optimization software is reducing utility costs and improving sustainability metrics that matter for both tenants and investors. Every one of these upgrades feeds back into value. For brokers, investors, and developers, the opportunity is in knowing how to use these insights. AI does not replace judgment, but it does sharpen it. It highlights risks earlier, surfaces opportunities faster, and helps transform raw data into decisions that move the needle. The ones who learn to combine local market knowledge with AI-driven tools will not just compete in this space—they will lead it. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact

Medical real estate investment trusts have been under a microscope this year. With higher interest rates and questions about operator stability, investors have been waiting for cracks to show. But what is happening now is not collapse, it is recalibration. Some of the largest players are selling off non-core properties, paying down debt, and tightening portfolios around assets with stronger tenant credit. Others are leaning into niche segments like behavioral health and post-acute, betting that demand will outpace short-term pressure from rates. These moves matter because REITs often set the tone for how capital views the entire sector. When they adjust strategy, private investors and lenders tend to follow. For brokers and operators, the message is clear. Deals are still closing, but underwriting is sharper and the gap between high-quality and weaker assets is widening. Properties with strong tenants, flexible layouts, and stable reimbursements are attracting capital. Those without these fundamentals are lingering longer and facing more aggressive price discovery. This is where a sharper lens on market intelligence becomes critical. With the right tools, it is possible to cut through the noise, understand what is truly driving value, and position assets to capture attention even in a tighter environment. 📅 Book a call: https://calendly.com/contact-loveladyperspective/15min 📬 Subscribe for weekly insights: https://www.loveladyperspective.com/contact